Possible roles of transglutaminases in Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 2, 1998, Pages 103-110

  Yamada, T ^a,f   Yosshiyama, Y ^a   Kawaguchi, N ^a   Ichinose, A ^b   Iwaki, T ^c   Hirose, S ^d   Jefferies, W A ^e  

^a CHIBA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f FUKUOKA UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Astrocyte; Factor XIIIa; Human brain; Microglia; Tissue transglutaminase

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 13A; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EPENDYMA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MENINX; MICROGLIA; NEUROFIBRILLARY TANGLE; PARIETAL LOBE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0031917140     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017031     Document Type: Article

References (25)

1. Ikura K, Takahata K, Sasaki R: Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimerβ/A4 amyloid protein by transglutaminase. FEBS Lett 1993;326:109-111.
2. Gentile V, Saydak M, Chiocca A, Akande O, Birckbichler PJ, Lee KN, Stein JP, Davies PJ: Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem 1991;266:478-483.
3. Philips MA, Stewart BE, Qin Q, Chakravarty R, Floyd EE, Jetten AM, Rice RH: Primary structure of keratinocyte transglutaminase. Proc Natl Acad Sci USA 1990;97:9333-9337.
4. Akiyama H, Kondo H, Arai T, Kato M, McGeer PL: Immunohistochemical detection of coagulation factor XIIIa in postmortem human brain tissue. Neurosci Lett 1995;202:29-32.
5. Iwaki T, Miyazono M, Hitotsumatsu T, Tateishi J: An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes. Am J Pathol 1994; 145:776-781.
6. Henriksson P, Becker S, Lynch G, McDonagh J: Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 1985;76:528-534.
7. Weisberg LJ, Shiu DT, Conkling PR, Shuman MA: Identification of normal peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIIIa-chain. Blood 1987;70: 579-582.
8. Barry ELR, Mosher DF: Factor XIII cross-linking of fibronectin at cellular matrix assembly sites. J Biol Chem 1988;263:10464-10469.
9. Alaoui SEL, Mian S, Quash G, Griffin M: Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis) FEBS Lett 1992;311:174-178.
10. Upchurch HF, Conway E, Patterson MK, Maxwell MD: Localization of cellular transglutaminase on the extracellular matrix after wounding: Characteristics of the matrix bound enzyme. J Cell Physiol 1991;149:375-382.
11. Kojima S, Nara K, Rifkin DB: Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol 1993;121:439-448.
12. Dudek SM, Johnson GVW: Transglutaminase facilitates the formation of polymers of the β-amyloid peptide. Brain Res 1994;651:129-133.
13. Ho GJ, Gregory EJ, Smirnova IV, Zoubine MN, Festoff BW: Cross-linking of β-amyloid protein precursor catalyzed by tissue transglutaminase. FEBS Lett 1994;349:151-154.
14. Rasmussen LK, Sorensen ES, Petersen TE, Gliemann J, Jensen PH: Identification of glutamine and lysine residues in Alzheimer amyloid βA4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to α2M receptor. FEBS Lett 1994;338:161-166.
15. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Yolk B, Berber M: Interleukin-6 and α2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 1991;285:111-114.
16. Dudek SM, Johnson GVM: Transglutaminase catalises the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of τ. J Neurochem 1993;61:1159-1162.
17. Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, McGeer PL: Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res 1996;712:122-126.
18. Ichinose A, Hendrickson LE, Fujikawa K, Davie EW: Amino acid sequence of a subunit of human factor XIII. Biochemistry 1986;25: 6900-4906.
19. Wisniewski HM, Weigel J, Kotula L: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol 1996;22:3-11.
20. Davies PJA, Davies DR, Levitzki A, Maxfield FR, Milhaud P, Willingham MC, Pastan IH: Transglutaminase is essential in receptor-mediated endocytosis of α2-macroglobulin and polypeptide hormones. Nature 1980;283:162-167.
21. Sottrup-Jensen L, Stepanik TM, Wierzbicki DM, Jones CM, Lonblad PB, Kristensen T, Mortensen SB, Petersen TE, Magnusson S: The primary structure of α2-macroglobulin and localization of a factor XIIIa cross-linking site. Ann NY Acad Sci 1983;421:41-60.
22. Sane DC, Moser TL, Pippen AMM, Parker CJ, Achhyuthan KE, Greenberg CS: Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun 1988;157:115-120.
23. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD: Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J Neurol Res 1996; 43:190-202.
24. McGeer PL, McGeer EG: The inflammatory response system of brain: Implication for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 1995;21:195-218.
25. Tooyama I, Kawamata T, Akiyama H, McGeer PL: Immunohistochemical study of α2-macrcglobulin receptor in Alzheimer and control postmortem human brain. Mol Chem Neuropathol 1993;18:153-160.